Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSF

Luigi Dolcetti, Elisa Peranzoni, Stefano Ugel, +9

European Journal of Immunology

ImmunologyImmune RegulationImmune SystemImmunotherapyTumor Biology +15

Purinergic Control of T Cell Activation by ATP Released Through Pannexin-1 Hemichannels

Ursula Schenk, Astrid M. Westendorf, Enrico Radaelli, +7

Science Signaling

A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome

Veronica Marrella, Pietro Luigi Poliani, Anna Casati, +14

Journal of Clinical Investigation

Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events

Giuseppe Mancia, Michele Bombelli, Rita Facchetti, +5

Journal of Hypertension

Clinical-scale selection and viral transduction of human naïve and central memory CD8+ T cells for adoptive cell therapy of cancer patients

Anna Casati, Azam Varghaei-Nahvi, Steven A. Feldman, +4

Cancer Immunology Immunotherapy

Immunological MemoryCell TherapyCancer ImmunosurveillanceViral TransductionImmunology +8

Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications

Veronica Marrella, Pietro Luigi Poliani, Elena Fontana, +11

Blood

Brentuximab vedotin exerts profound antiproliferative and pro‐apoptotic efficacy in CD30‐positive as well as cocultured CD30‐negative germ cell tumour cell lines

Stefan Schönberger, Cornelius van Beekum, Barbara Götz, +7

Journal of Cellular and Molecular Medicine

The Immunogenicity of Dendritic Cell-Based Vaccines Is Not Hampered by Doxorubicin and Melphalan Administration

Anna Casati, Valérie S. Zimmermann, Fabio Benigni, +3

The Journal of Immunology

Differential effects of enalapril–felodipine versus enalapril–lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension

Gino Seravalle, Gianmaria Brambilla, Daniela Prata Pizzalla, +5

Journal of the American Society of Hypertension

HypertensionMetabolic ProfileCardiovascular DiseaseMedicineSympathetic Nervous System +8

The <scp>FDA</scp> approved <scp>PI</scp>3K inhibitor <scp>GDC</scp>‐0941 enhances <i>in vitro</i> the anti‐neoplastic efficacy of Axitinib against c‐myc‐amplified high‐risk medulloblastoma

Michael Ehrhardt, Rogerio B. Craveiro, Julia Velz, +5

Journal of Cellular and Molecular Medicine